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Abstract
Background: The zoonotic parasite Taenia solium is endemic in Angónia district, Tete province, Mozambique,
though the burden of the disease complex is unknown.
Methods: As part of two cross-sectional studies on human and porcine cysticercosis in the area, unique
epidemiological and cost data were collected in Angónia district, Mozambique in 2007. These data provided the
basis for the assessment of the societal cost of T. solium in the district, which estimates the impact of the disease
on human and pig populations and includes both health and economic approaches in the analysis.
Results: Approximately 0.7% (95% Uncertainty Interval (UI), 0.4–0.9) and 0.4% (95% UI, 0.2–0.6) of the total population
in the district was estimated to suffer from neurocysticercosis (NCC)-associated epilepsy and headache. The estimated
average number of disability-adjusted life years (DALYs) due to NCC-associated epilepsy and headache was 6 (95% UI,
4–8) per thousand persons per year. The total annual costs due to T. solium cysticercosis were estimated at
90,000 USD (95% UI, 39,483–201,463) of which 72% (95% UI, 45–91) were costs linked to human cysticercosis
and 28% (95% UI, 9.5–55) to pig production losses. The annual economic burden per NCC-associated epilepsy
case in the district amounted to 33 USD (95% UI, 10–76).
Conclusions: In this highly endemic area of Mozambique a large number of individuals suffer from symptoms
associated with NCC. Healthy years of life are lost and people are left living with disabilities. Infected pork poses a
serious risk to the community and affects the economy of smallholder farmers. Cost for treatment and hospitalization
of patients with NCC-associated epilepsy, and lack of productivity and inability of suffering patients to work, further
hinder socioeconomic development. Feasible solutions framed within a country specific algorithm and stepwise
approaches are needed to control the parasite in the country.
Keywords: Taenia solium taeniosis/cysticercosis, Neurocysticercosis, Epilepsy, Migraine, Tension-type headache,
Disability-adjusted life years: Societal cost, Zoonoses
Background
Taenia solium taeniosis/cysticercosis (TSTC) is a zoo-
notic disease complex currently challenging the public
health and agricultural sectors in many low-income
countries. Taenia solium is endemic in countries of
Africa, Asia and Latin America, hindering growth and
socioeconomic development [1–3].
Humans acquire the adult tapeworm (taeniosis) by
eating raw or undercooked pork containing cysticerci.
Cysticercosis is contracted by both humans and pigs
after accidentally ingesting T. solium eggs in faeces from
humans harbouring the adult tapeworm. In humans
cysticerci may lodge in the central nervous system
leading to neurocysticercosis (NCC). The disease may
cause severe disorders, the most common being epilepsy
and headache [4], though people can also remain asymp-
tomatic [5].
Recent findings reported that seizures also occur in
pigs with NCC and disease negatively affects their
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behaviour, posing a further burden on the welfare of
affected animals [6, 7].
In 2013, the World Health Assembly passed the
WHA66.12 resolution with the aim of eliminating TSTC
as a public health problem [8]. Recent results of a study
coordinated by the Foodborne Disease Burden Epide-
miology Reference Group ranked T. solium as the most
important foodborne parasite in the world causing a
great number NCC-associated epilepsy cases and deaths,
resulting in 2.8 million disability-adjusted life years
(DALYs) [9]. In parallel to these studies, country-specific
studies have been conducted to estimate the health and
economic burden of TSTC [10–14]. These highlighted
the lack of representative country-specific data and the
necessity of making assumptions, possibly leading to
under- or overestimations of the impact of the parasite
on human and pig populations.
During the past decade studies on T. solium were con-
ducted in Angónia district and results have shown that
the parasite and all conditions for its transmission are
present [15, 16]. The parasite is likely to pose a large
burden to smallholder farmers and their society in this
area of the country. Angónia district is part of Tete
province, located in north-western Mozambique. Small-
holder farmers living in close relation to their animals
mostly populate the area. Pig production plays a major
role in the families’ economic activity in the district [17].
In recent years the number of pigs per family has
increased as farmers have seen pigs to have a quick
economic turnover and are easily raised as they can be
left to roam freely. However, the economic growth and
development of the area has been hindered by many
post-civil war socio-economic and political challenges
[18]. Political instability has led to the regress of the dis-
trict, making it one of the poorest of the country [19].
Lack of access to health care, education, water supply
and sanitation constantly exacerbate the poor living con-
ditions of smallholder farmers and their families.
The present study aimed at quantifying the societal
cost of T. solium in Angónia district by estimating the
impact of the disease on human and pig populations and
including both health and economic approaches in the
analysis.
Methods
Study area and population
In 2007 the total human population of the district was
330,328 people. The main occupation and most import-
ant economic activity of the district was mixed farming,
including pig rearing. Pigs were mostly free-roaming
during the day and dry seasons and kept confined at
night and during the rainy, crop growing season [17, 20].
Health care access was limited in the district with only
one rural hospital, four health centres and three health
points and inhabitants commonly consulted traditional
healers. No computed tomography (CT) scanner was
available [17].
Necessary conditions for transmission of the parasite
were present, namely lack of knowledge about T. solium,
open defecation, poor sanitation, free roaming pigs, lack
of slaughtering facilities with qualified meat inspectors,
home slaughtering and consumption of uninspected and
undercooked pork [15, 20].
Between September and November 2007 two cross-
sectional studies on human and porcine cysticercosis,
respectively, were conducted in Angónia district,
Mozambique. The lifetime prevalence of epilepsy, where
screen-positive individuals were reviewed and confirmed
by a neurologist, was estimated including 1723 study
subjects in the study and the results on the proportion
of patients with epilepsy suffering from NCC were re-
ported according to Del Brutto et al. (2001) [21] criteria
[15]. Proportions of severe progressive headache (mi-
graine and tension-type) among patients with epilepsy
were based on answers provided by structured inter-
views from questionnaire developed by the Cysticercosis
Working Group in Eastern and Southern Africa
(CWGESA) [22, 23]. Pondja et al. (2010) [20] conducted
a study to estimate the prevalence of porcine cysticerco-
sis including 661 pigs from 306 households in 11 villages
across the district. The B158/B60 ELISA detecting circu-
lating cysticercus antigens and tongue examination for
submucosal cysticerci were used to diagnose porcine
cysticercosis.
Health burden assessment
The health burden for the year 2007 was assessed by esti-
mating the annual number of NCC-associated epilepsy,
migraine and tension-type headache cases, and the result-
ing number of deaths and DALYs. Table 1 presents the pa-
rameters and related distributions used in the analysis.
Epilepsy was defined as two or more unprovoked
seizures unrelated to any acute intracranial disease
(e.g. cerebral malaria, meningitis), acute metabolic
disorders, withdrawal of drugs or use of alcohol and
occurring at least 24 h apart [24]. Lifetime prevalence
of epilepsy was defined as the proportion of patients
identified with a history of epilepsy at any time, re-
gardless of treatment or recent seizure activity, while
active epilepsy was defined as having had at least one
seizure in the past year and receiving or having
received treatment [25]. The prevalence of active
epilepsy was 1.3% (95% Uncertainty interval (UI), 0.8–
2.0), obtained by dividing the number of lifetime epi-
lepsy patients receiving epilepsy treatment by the total
number of study participants [23].
Patients with NCC might experience headaches
that can present as migraine or tension-type
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Table 1 Parameters used to estimate the health burden due to NCCa-associated epilepsy and headache (migraine and tension-type)
in Angónia district
Parameter Mean (95% UIb) Distributions Reference
Mortality due to epilepsy
per 1000
0.08 (0.076–0.084) Uniform
(7.6e-05, 8.4e-05)
[28]
Prevalence of active epilepsy (%) 1.3 (0.8–1.9) Beta
(22, 1701)
[15]
Proportions
Epilepsy associated to NCC (%) 51 (43–59) Uniform
(0.427, 0.592)
[15]
Epilepsy patients receiving treatment (%) 15 (9.4–21) Beta
(22, 129)
[15]
Headache among people with lifetime epilepsy (%) 62 (54–70) Beta
(94, 57)
[23]
Migraine among people with headache and epilepsy (%) 39 (30–50) Beta
(37, 57)
[23]
Tension-type headache among people with headache and epilepsy (%) 61 (50–70) Beta
(57, 37)
[23]
Disability weights
Epilepsy GBDc 2010 [31]
Untreated 0.426 (0.286–0.565) Uniform
(0.279, 0.572)
Treated, seizure free 0.076 (0.048–0.105) Uniform
(0.047, 0.106)
Headache GBDc 2013 [32]
Migraine 0.441 (0.301–0.581) Uniform
(0.294, 0.588)
Tension-type 0.040 (0.023–0.056) Uniform
(0.022, 0.057)
a NCC neurocysticercosis; b UI uncertainty interval; c GBD 2010, 2013: Global Burden of Disease Study 2010 and 2013
Fig. 1 Health outcome tree to estimate the proportion of patients with NCC-associated epilepsy, migraine and tension-type headache in Angónia
district, Mozambique
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headache [26, 27]. Periods of recurrent headaches
were reported by 94 of 151 patients with lifetime
epilepsy. Of these 94 patients had migraine and the
rest had tension-type headache (Table 1).
The burden was estimated among people with
NCC-associated epilepsy, and headache was added as
an extra burden on a subset of patients identified
having NCC-associated epilepsy. A health outcome
tree (Fig. 1) was used to obtain the proportions of
the population with epilepsy, migraine and tension-
type headache due to NCC.
To estimate the mortality due to NCC-associated
epilepsy, the WHO mortality rate (2008) for epilepsy
in Mozambique was multiplied by the proportion of
NCC-associated active epilepsy in Angónia district
[15, 28]. Data on mortality due to headache could
not be retrieved, hence it was assumed that mortality
due to migraine and tension-type headache would
not occur.
The number of DALYs was estimated using known
methods [29, 30]. In short: DALYs were obtained by
summing years lived with disability (YLD) and years
of life lost (YLL). The formulas used for the DALY
calculation are described in eqs. 1 and 2.
YLD ¼ P DW ð1Þ
Where ‘P’ represents the number of prevalent cases
and ‘DW’ is the disability weight.
Table 2 Parameters used to estimate the economic burden of T. solium in Angónia district, Mozambique
Parameter Mean (95% UIa) Distribution Reference
Study zone population 330,328 Fixed [17]
Active epilepsy (%) 1.3 (0.8–2.0) Beta
(22, 1701)
[15]
NCC-associated epilepsy (%) 51 (43–59) Uniform
(0.427, 0.592)
[15]
Epilepsy patients consulting a traditional healer (%) 23 (18–28) Multinomial
(0.227)
[23]
Epilepsy patients consulting a physician, a nurse or neurologist (%) 9.1 (6–13.4) Multinomial
(0.091)
[23]
Epilepsy patients without treatment (%) 68 (62–74) Multinomial
(0.682)
[23]
Visits to a traditional healer in case of epilepsy (average times per year) 5.5 (1.2–9.8) Uniform
(1, 10)
[23]
Visits to a doctor in case of epilepsy (average times per year) 4.5 (1.2–7.8) Uniform
(1, 8)
[23]
Epilepsy patients with prescribed phenobarbital (%) 44 (33–55) Beta
(36, 46)
[23]
Epilepsy patients with injury referred to the hospital (%) 15 (11–20) Beta
(38, 222)
[23]
Length of stay in a hospital (average days per year) 11 (1.5–20) Uniform
(1, 21)
[23]
Loss of working time due to epilepsy (days per year) 16 (1.7–29) Uniform
(1, 30)
[23]
Unemployed due to epilepsy (%) 2.2 (0.9–5.1) Beta
(6, 261)
[23]
Working days per year 266 (222–310) Uniform
(220, 312)
Assumption
% of the population
Economically active 40 Fixed [17]
Not economically active 47 Fixed [17]
Unemployed 14 Fixed [17]
Pig population in the study area 20,411 Fixed Assumption
Proportion of adult pigs sold per year (%) 33 Fixed Assumption
Porcine cysticercosis prevalence based on tongue examination (%) 13 (10–16) Beta
(84, 577)
[20]
a UI Uncertainty interval
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YLL ¼ N L ð2Þ
Where ‘N’ is the number of deaths caused by disease
per year and ‘L’ is the life expectancy at the age of death
in years.
Disability weights for epilepsy, migraine and tension-
type headache were based on those of the GBD study
2010 and 2013 [31, 32]. For life expectancy parameters,
the GBD 2010 life expectancy table was used where life
expectancy at birth is 86 years [33].
Results were computed using two variants of
DALYs[K;r] (with K the age weighting constant and r
the discount rate) and using a prevalence approach.
The base case DALYs[0;0] were estimated without age
weighting or time discounting, in line with current
practice.
Economic burden assessment
The epidemiological and economic parameters used for
the economic assessment are summarised in Tables 2
and 3.
Direct and indirect costs related to both human and
porcine cysticercosis were included in the assessment.
Direct costs related to human health included expenses
for treatment such as: medical care, medicine and hospi-
talisation for patients with NCC-associated epilepsy. The
price of a visit to a traditional healer in Angónia district
varied from visit to visit hence an average price was
calculated.
The indirect costs or productivity losses included
the expenses related to individuals who were unable
to go to work or unemployed because of NCC-
associated epilepsy.
The number of working days per year was estimated
at a minimum of 220 and a maximum of 312 days in
order to take differences between the formal and infor-
mal sector into account.
A decision tree (Fig. 2) was used to obtain the propor-
tions of the population with epilepsy due to NCC, with
or without injury, treatment and hospitalization. The pa-
tients without injury were divided into those who sought
medical care and those who did not. The patients with
NCC-associated epilepsy that sought medical care were
divided into: patients consulting a traditional healer and
patients consulting a medical doctor, nurse or neurolo-
gist. It was assumed that all patients that got injured
during an epileptic seizure would refer to the hospital
and be hospitalized and the ones without injury, that
sought medical care, would be treated as out-patients.
For the estimation of the losses due to porcine cysti-
cercosis, the cysticercosis prevalence based on tongue
examination, 12.7% (95% UI, 10.3–15.5), was used. The
prevalence was estimated on a sample of 661 pigs from
Angónia district [20]. In Angónia district it was common
practice for farmers to sell the pigs to pig traders who at
purchase, would inspect the pig’s tongue for cysticercosis
and agree on the price. The price of a pig depended on
presence or absence of infection and the animal’s size. In
the region, the average price reduction of a cysticercosis
infected pig at slaughter was of 50% (Gule, personal
communication). This was the only agricultural factor
taken into account, as porcine cysticercosis has so far
not shown to have an effect on animal’s productivity [4].
Losses due to carcass condemnation were not taken into
account. In Angónia district meat inspection was present
only at one market place, therefore the likelihood of
infected meat reaching market there was very low [34].
Because reliable information on the number of
slaughtering pigs was not available, the slaughtering pig
population was estimated at 20,411 pigs. This number
was based on the assumption that a smallholder pig
farmer in Angónia district on average slaughtered one
pig annually, and pigs were present in every fourth
household [17]. We further assumed that only one third
of the slaughtering pigs would be sold per year, as pig
Table 3 Cost parameters in USD used to estimate the economic burden of T. solium in Angónia district, Mozambique
Parameter Mean (95% UIa) Distribution Reference
Average monthly salary 104 (30–178) Gamma
(5.3, 0.06)
[43]
Cost of a visit to a physician (public hospital) 3.1 (2.1–4.1) Gamma
(33.4, 11.1)
[44]
Cost of a traditional healer 63 (25–101) Gamma
(8.5, 0.15)
[23]
Cost of one day at the hospital 2.3 Fixed [44]
Antiepileptic drugs
(2 weeks treatment)
5 Fixed [23]
Value of an adult pig 55 (30–79) Gamma
(16.5, 0.32)
(Gule, personal communication)
Value reduction of infected pork (%) 50 Fixed (Gule, personal communication)
a UI Uncertainty interval
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production for personal consumption is common in the
area [20].
Health and economic burden assessment analyses
All analyses were performed in R 3.2.2 [35]. Scripts are
available online at https://github.com/brechtdv/tsol-
mozambique. The uncertainty of the parameters was
modelled using Monte Carlo simulations. This allowed
calculating 95% uncertainty intervals (UI) for each result.
Different distributions were used according to the type
of information available for each of the variables in
Tables 1, 2 and 3. The number of iterations was set to
100,000. Sensitivity analyses were conducted to show the
contribution of each uncertain variable to the overall
uncertainty of the end result. The impact of the uncer-
tainty in the different parameters on the overall uncer-
tainty in total DALYs, costs and potential losses is
shown by the partial correlation coefficients presented in
the results section.
Results
Health burden assessment
Approximately 0.7% (95% UI, 0.4–0.9) and 0.4% (95%
UI, 0.2–0.6) of the total population in the district was es-
timated to suffer from NCC-associated epilepsy and
headache, respectively. Around 85% (95% UI, 79–91) of
the diseased population never received any treatment
(Table 4). Overall, it was estimated that NCC-associated
Fig. 2 Decision tree to estimate the economic burden of NCC-associated epilepsy in Angónia district, Mozambique
Trevisan et al. BMC Infectious Diseases  (2018) 18:127 Page 6 of 11
epilepsy, migraine and tension-type headache led to
more than 2003 (95% UI, 1433–2762) healthy life years
lost (Table 5), meaning 6 (95% UI, 4–8) DALYs per 1000
persons per year. Non-fatal health outcomes were found
to be the largest contributors to the overall health
impact (53% (95% UI, 39–65). YLDs associated with
NCC-headache contributed to 13% (95% UI, 8–19) of
the total DALY estimate.
When using non-uniform age weighting and a 3%
discount rate, the estimated number of DALYs[1;0.03]
was 1618 (95% UI, 1042–2411) and the estimated num-
ber of DALYs[1;0.03] per thousand person per year was
4.9 (95% UI, 3.2–7.2). Of the total DALYs[1;0.03], 73%
(95% UI, 61–82) were attributed to YLD and 27% (95%
UI, 18–39) to YLL, respectively.
Economic burden assessment
Taenia solium led to an economic loss of around 90,000
USD (95% UI, 39,483–201,463) of which 72% (95% UI,
45–91) were costs linked to human cysticercosis and
28% (95% UI, 9.5–55) were due to pig production losses
(Table 6). The annual economic burden per case of
NCC-associated epilepsy in the district amounted at 33
USD (95% UI, 10–76). The economic burden of NCC-
associated epilepsy was dominated in particular by the
production losses. Direct costs due to hospitalization
were the next major contributor to the losses, although
contributed only to 12% (95% UI, 5–24) of the total
costs for NCC-associated epilepsy.
Agricultural losses due to reduced value of slaughtered
pigs accounted for almost one third of the total costs
(28% (95% UI, 9.5–55)).
Sensitivity analyses
Figures 3 and 4 show the partial correlations coefficients,
displaying the impact of the different parameters on the
uncertainty of the overall estimates.
Discussion
The study has shown that in this T. solium endemic area
of Mozambique the parasite affects the livelihood of
subsistence farmers and their society by reducing their
societal and economic wellbeing. Based on data, col-
lected in parallel from human and pigs in Angónia
district, the present assessment revealed that NCC-
associated epilepsy and headache led to 6 (95% UI, 4–8)
DALYs per thousand persons per year, costing this soci-
ety more than 90,000 (95% UI, 39,483–201,463) USD.
Table 4 Estimated number of people with NCC-associated epilepsy, migraine and tension-type headache, people suffering without
treatment, people dying due to NCC-associated epilepsy and pigs with cysticercosis in Angónia district, Mozambique
Estimate Mean (95% UIa) % of total population (95% UIa)
Annual number of prevalent cases of NCC-associated epilepsy 2151 (1299–3249) 0.7 (0.4–0.9)
People with NCC-associated epilepsy without treatment 1837 (1103–2788) 0.6 (0.3–0.8)
Number of deaths due to NCC-associated epilepsy 14 (11–16) 0.004 (0.003–0.005)
Annual number of prevalent cases of NCC-associated migraine 527 (290–855) 0.2 (0.1–0.3)
Annual number of prevalent cases of NCC-associated tension-type headache 812 (468–1274) 0.2 (0.1–0.4)
Number of pigs with cysticercosis 2595 (2098–3133) 12.7 (10.3–15.3)
a UI Uncertainty interval
Table 5 Estimated prevalent Years Lived with Disability (YLDs), Years of Life Lost (YLLs) and Disability-Adjusted Life Years (DALYs) for
NCC-associated epilepsy, migraine and tension-type headache in Angónia district, Mozambique
Estimate Mean (95% UIa) % contribution
to total DALY (95% UIa)
YLD NCC-associated
epilepsy
806 (415–1368) 39 (28–51)
YLD NCC-associated
migraine
233 (111–415) 11 (7–18)
YLD NCC-associated
tension-type headache
32 (14–59) 1.6 (0.8–2.6)
YLL NCC-associated
epilepsy
932 (781–1088) 47 (35–61)
Total DALYs* 2003
(1433–2762)
100
DALYs per 1000 persons 6 (4–8) 100
a UI Uncertainty interval
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Compared to other studies assessing the burden of T.
solium, the estimated DALYs of this study were higher
whereas the cost estimates for the district were lower.
This study is the third to use DALYs to estimate the
health burden of T. solium in Africa and the second to in-
clude headache data in the assessment. In Africa, the first,
carried out in Cameroon, estimated a number of 9.0
DALYs per 1000 person-years [13], while the second, car-
ried out in Tanzania, estimated a number of 0.7 DALYs
per 1000 person-years [14]. Health burden assessments
have also been performed in Mexico, Nepal and India,
where the author estimated 0.25 (0.12–0.46), 0.5 (0.2–1.1)
and 1.7 (0.8–3.4) DALYs per thousand persons per year,
respectively [10, 12, 36]. The reason for the high health
burden in Angónia district is likely to be an added effect
of a) being a rural area with low socio-economic status, b)
the presence of all risk factors for T. solium and c) no
awareness of the disease in the health or agricultural sec-
tors. In Angónia district, the prevalence of epilepsy was
twice as high and the proportion of NCC in subjects with
epilepsy was three times as high compared to Tanzania.
To estimate the years of life lost we used the GBD 2010
life expectancy, these increased the results1.25 fold com-
pared to using the standard life expectancy table of Coale-
Demeny [37] and finally the inclusion of headache further
increased the result 1.1 fold.
In Angónia district around 85% (95% UI, 79–91) of
the patients with NCC-associated epilepsy never
received treatment while in Tanzania over half of the
diseased population was left untreated. As the disability
weights for untreated epilepsy cases are higher than the
ones for treated epilepsy, a higher number of DALYs per
1000 persons per year was expected in the district.
Headache data were included for the first time in an
assessment of the burden of T. solium in Africa. Based
on the data, the model estimated that in Angónia district
0.4% (95% UI, 0.2–0.6) of the total population suffered
from NCC-associated headache. Bhattarai et al. (2012)
assessed the burden of NCC-associated headache in
Mexico and estimated that 0.08% of the population was
suffering. The results in the current study are five times
higher. In this study, headache was added as an add-
itional burden on a subset of patients with NCC-
associated epilepsy, partly explaining a higher burden in
Angónia district. To estimate the burden of NCC-
associated headache in Mexico, Bhattarai et al. (2012)
used the proportion of NCC-associated headache found
in a systematic review by Carabin et al. (2011). As the
review did not mention what type of headache was taken
into consideration, we preferred not to use such extrapo-
lation but use a different approach. In this study mi-
graine and tension-type headache were added as an
additional burden for a subset of patients with NCC-
associated epilepsy, however NCC associated headache
in non-epileptics was not calculated.
In our assessments the contribution of YLD and YLL
to the total DALY was 53% and 47%, respectively. These
figures indicate that in this study the disease had almost
an equal impact on the life quality and life loss of the
Table 6 Estimated direct and indirect annual costs due to T.
solium in humans and pigs in Angónia district, Mozambique
Type of cost Mean USD (95% UIa)
Hospital 7945 (4312–13,019)
Antiepileptic treatment 1501 (1038–2100)
Medical doctor (public hospital) 14 (3–27)
Traditional healer 312 (56–758)
Inactivity 61,462 (11,131–166,964)
Pig losses 22,282 (12,315–35,647)
Total costs 93,370 (39,483–201,463)
Price per NCC-associated epilepsy case 33 (10–76)
a UI Uncertainty interva
Fig. 3 Partial correlation coefficients showing which parameter influences the estimated DALYs due to NCC-associated epilepsy, migraine and
tension-type headache for the year 2007 in Angónia district, Mozambique. E-epilepsy; NCC-neurocysticercosis; PWE-people with epilepsy; M-
migraine; TTHA-tension-type headache
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inhabitants. However when using non-uniform age
weighting and a 3% discount rate 73% (95% UI, 61–82)
were attributed to YLD and 27% (95% UI, 18–39) to
YLL, respectively, in contrast with results of the study in
Cameroon, where the percentages of YLD and YLL were
15% and 85%, respectively.
The results of the cost estimation showed that T. solium
contributes to a high economic impact in Angónia district.
Around 90,000 USD were lost due to the disease annually.
Per NCC-associated epilepsy case the annual economic
burden in the district amounted at 33 USD (95% UI, 10–
76). Compared to other studies that assessed the eco-
nomic burden of T. solium, these results are low. In
Tanzania and Cameroon, the cost per NCC-associated
epilepsy case was more than three and seven times higher,
respectively. The difference can partly be explained by the
large treatment gap, and partly by the low treatment costs.
The losses due to inactivity were 82% of the costs for
NCC-associated epilepsy. This percentage is in line with
that in Cameroon, where 89% of the total costs due to
NCC-associated epilepsy were lost due to inactivity and
Tanzania where around half the total costs were due to
unemployment and/or inactivity of patients with NCC-
associated epilepsy.
The losses due to porcine cysticercosis were esti-
mated to be around 22,000 USD (0.07 USD per capita
per infected pigs). This result is in line with estimates
from Cameroon, where two studies found that 0.10
Euro per person per infected pig were lost [13, 38].
In Eastern Cape Province, South Africa the annual
loss per person per infected pig was 0.60 Euro. The
differences in losses might be reflected by the disease
prevalence, the price reduction due to infection and
pig value. The higher losses in Angónia district and
in South Africa may be due to the higher prevalence
of porcine cysticercosis observed in these two areas
and to a different price reduction used in the
estimations. In Angónia district the average value of
an adult pig was 55 USD, while in Cameroon it was
almost the double (100 Euro). Furthermore, in
Angónia district the price reduction of a pig diag-
nosed with cysticercosis was 50%, while in Cameroon
30% (Gule, Personal communication) [13].
Angónia district was characterized by Pondja et al.
(2010) as a rural area with very high level of illiteracy,
free roaming pigs, lack of proper slaughtering facilities,
frequent consumption of undercooked, uninspected
pork, open latrines allowing pigs’ free access, and no
awareness of transmission of the diseases or ways to
control it. According to FAO, the pig population in
Mozambique has increased from 170,000 to 1.4 million
in 20 years, an eight fold increase, which is most signifi-
cant in the North [39]. With the increase of the pig
population and the presence of risk factors for parasite
transmission, the burden of this zoonosis will further ex-
acerbate the life of people and pigs living in the district.
Our study has some limitations. Due to lack of infor-
mation on frequency and disability weights, only the
most frequent clinical symptoms of NCC (epilepsy and
headache) were included in the estimates [40]. Headache
is a common and non-specific symptom, and while it is
a recognized association with NCC it is often not diag-
nosed as a symptom associated with NCC as such. In
this burden assessment headache was only included as
an additional symptom among the patients suffering
from NCC-associated epilepsy, possibly leading to an
under-estimated total burden.
The proportion of the total costs due to hospitalization
was attributed to the assumption that patients injured
during an epileptic seizure would be hospitalized.
Furthermore in Africa the causes of epilepsy are often
attributed to supernatural forces that lead to
stigmatization, marginalization and exclusion of diseased
people [23]. These are social aspects that are difficult to
Fig. 4 Partial correlation coefficients showing which parameter influences the estimated economic burden due to NCC-associated epilepsy and
porcine cysticercosis for the year 2007 in Angónia district, Mozambique. E-epilepsy; PC-porcine cysticercosis NCC-neurocysticercosis; PWE-people
with epilepsy
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capture however recently the Kilifi Stigma Scale for Epi-
lepsy, a new tool to measure perceived stigma among
people with epilepsy was developed and validated [41].
This tool could assess in a study on young people with
epilepsy conducted in Tanzania the impact of epilepsy
on social transitioning outcomes and showed that these
pupils with epilepsy were more likely to experience un-
favorable educational, relationship and employment out-
comes in the transition to adult life than controls [42].
This calls for models for disease burden estimates to be
further improved and include sociological aspects to
provide a more accurate and comprehensive estimate of
the burden of disease.
In regards to porcine cysticercosis, due to the unavail-
ability of a reliable number of the total pig population,
this number had to be estimated. This will lead to in-
accuracy in the derived prevalence and thus number of
infected pigs and pig production losses. Furthermore,
with the lack of organized/official market for pigs and
associated listing, the value of a pig slaughtered/sold will
remain a qualified estimate. The same regards the per
cent loss in value due to cysticercosis – a reduced price
may change the decision of a farmer to slaughter or sell.
It should be underlined that the epidemiological pa-
rameters used to estimate the health and economic bur-
den in this study were collected in parallel from humans
and pigs in a specific district in northern Mozambique,
which is different from other studies.
From the results of this study and the comparison with
the studies carried out previously on the burden of T.
solium it is important to underline that both, the health
and economic estimations depend on prevalence esti-
mates, therefore it is essential to have accurate data in
order to generate accurate burden estimates.
Conclusion
Results of this study showed that in Angónia district,
Tete province, Mozambique endemic to T. solium the
infection affects the livelihood of the subsistence farmers
by reducing their societal and economic wellbeing. A
large number of individuals suffer from NCC-associated
epilepsy and headache. Healthy years of life are lost and
people are left living with disabilities. Infected pork
poses a serious risk to the community and hinders the
economy of smallholder farmers. Cost for treatment and
hospitalization of patients with NCC-associated epilepsy,
and lack of productivity of suffering patients further lead
to an important obstacle to socioeconomic development.
Feasible solutions framed within a country specific al-
gorithm and stepwise approaches are needed to control
the parasite in the country.
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